Boston Scientific shares collapse as cybersecurity attack weighs on boards

Boston Scientific (BSX) stock slumped Wednesday after the medtech giant cut its 2026 outlook following a cybersecurity incident in August. For the year, the company now expects organic sales growth of 3.75% or 4.25% on a hard basis, as reported. It also forecast earnings per share of $3.16 to $3.18, less certain items. Three months ago, Boston Scientific called…